LGD-4033

Lean Muscle Mass LGD-4033 Fat Loss SARMS No Side Effects LGD-4033

Lean Muscle Mass LGD-4033 Fat Loss SARMS No Side Effects LGD-4033
LGD-4033 , LGD 4033
What is LGD-4033?
LGD-4033 is one of the newer SARMS that has come out. It is a non-steroidal oral SARM that binds with AR which produces steroid-like results minus thesteroids. It is the closest SARM that can be equated to an anabolic in terms of strength. Is the strongest of all the SARMS in terms of the size you can gain.

LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers this randomized, en double aveugle, placebo-controlled Phase I study established the safety and tolerability of doses up to 22mg.

It’s in a group of (AR) ligands that are tissue selective, created to cure muscle wasting linked with acute and chronic diseases, age-related muscle loss and cancer. LGD-4033 is anticipated to yield the healing benefits of testosterone with better safety, admissibility and patient acceptance due to tissue-selective mechanism of action and its oral form of administering.
LGD-4033 is 98.41% PURE as shown in the lab report below confirming that the purity and structure in LGD 4033 is of the absolute highest quality.

How LGD-4033 Works

LGD-4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo. The objective was to form that using LGD-4033 was harmless and easy to stomach with a dose not beyond 22 mg a day.
Clinical runs also showed that LGD-4033 has the ability to set off the following benefits when taken consistently:
An increase in strength levels
Lean muscle mass improved
A drop in body fat
Has healing properties
Does not cause the undesirable side effects caused by prohormones and anabolic steroids
When to Use LGD-4033
Based on some latest studies and experiments conducted, LGD-4033 can enhance lean muscle mass and decrease body fat. Aussi, it can boost strength for better and more challenging training performance, recovery and overall health. Ainsi, it comes as no surprise that athletes and bodybuilders use LGD-4033 to help them be in their best selves.

For Bulking
Suggested dosage is 5-10 mg a day for 8 semaines. A protein-rich diet is also necessary as well as higher caloric intake if you plan to beef up by 10 pounds or more.

For Cutting
Use LGD-4033 with SARMS triple pack (GW-501516, S-4 and LGD-4033) to make it more effective as you are aiming to add more size while cutting fat. Suggested dosage is 3-5 mg a day for 8 semaines.

For Recomping
LGD-4033 is best used for recomping. Many users have said that they’ve observed a boost in lean body mass and fat loss. Using it together with other SARMS such as or Cardarine will give you a stronger and better recomp. Suggested dosage is 5-8 mg per day for 8 semaines.

Does LGD-4033 Have Any Side Effects?

It is non-toxic and the side effects are very minimal. Ainsi, using LGD-4033 is recommended if you want to bulk up and drop fat sans steroids as we all knowsteroids have harsh side effects.
It won’t affect your liver but a full PCT is advised after running LGD-4033. The suppression is higher than other SARMS (but lower than anabolics), thus the need for PCT.

LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers this randomized, en double aveugle, placebo-controlled Phase I study established the safety and tolerability of doses up to 22mg.